Tavy Rosner
Stock Analyst at Barclays
(1.71)
# 3,421
Out of 5,102 analysts
58
Total ratings
31.11%
Success rate
-8.57%
Average return
Main Sectors:
Stocks Rated by Tavy Rosner
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NICE NICE Ltd. | Maintains: Overweight | $200 → $165 | $108.92 | +51.49% | 12 | Nov 19, 2025 | |
| CEVA CEVA, Inc. | Maintains: Overweight | $30 → $35 | $23.48 | +49.06% | 10 | Nov 12, 2025 | |
| TSEM Tower Semiconductor | Maintains: Equal-Weight | $74 → $97 | $128.94 | -24.77% | 2 | Nov 11, 2025 | |
| KRNT Kornit Digital | Maintains: Equal-Weight | $22 → $18 | $14.26 | +26.23% | 8 | Nov 6, 2025 | |
| MGIC Magic Software Enterprises | Maintains: Overweight | $16 → $18 | $26.79 | -32.81% | 5 | Aug 13, 2025 | |
| RDWR Radware | Maintains: Overweight | $30 → $35 | $24.22 | +44.51% | 7 | Jul 31, 2025 | |
| SPNS Sapiens International Corporation | Maintains: Underweight | $28 → $31 | $43.45 | -28.65% | 8 | May 9, 2025 | |
| ITRN Ituran Location and Control | Maintains: Overweight | $35 → $50 | $44.47 | +12.44% | 2 | Feb 27, 2025 | |
| DOX Amdocs | Maintains: Overweight | $113 → $111 | $78.82 | +40.83% | 4 | Nov 14, 2024 |
NICE Ltd.
Nov 19, 2025
Maintains: Overweight
Price Target: $200 → $165
Current: $108.92
Upside: +51.49%
CEVA, Inc.
Nov 12, 2025
Maintains: Overweight
Price Target: $30 → $35
Current: $23.48
Upside: +49.06%
Tower Semiconductor
Nov 11, 2025
Maintains: Equal-Weight
Price Target: $74 → $97
Current: $128.94
Upside: -24.77%
Kornit Digital
Nov 6, 2025
Maintains: Equal-Weight
Price Target: $22 → $18
Current: $14.26
Upside: +26.23%
Magic Software Enterprises
Aug 13, 2025
Maintains: Overweight
Price Target: $16 → $18
Current: $26.79
Upside: -32.81%
Radware
Jul 31, 2025
Maintains: Overweight
Price Target: $30 → $35
Current: $24.22
Upside: +44.51%
Sapiens International Corporation
May 9, 2025
Maintains: Underweight
Price Target: $28 → $31
Current: $43.45
Upside: -28.65%
Ituran Location and Control
Feb 27, 2025
Maintains: Overweight
Price Target: $35 → $50
Current: $44.47
Upside: +12.44%
Amdocs
Nov 14, 2024
Maintains: Overweight
Price Target: $113 → $111
Current: $78.82
Upside: +40.83%